BioCryst Pharmaceuticals, Inc.
Crystalline salts of a plasma kallikrein inhibitor
Last updated:
Abstract:
Disclosed are crystalline salts of Compound I, methods of preparing them, and related pharmaceutical preparations thereof. Also disclosed are methods of treatment using the crystalline salts of the invention. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
6 Feb 2020
Issue date:
14 Sep 2021